Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates
Salubris Biotherapeutics, a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, […]
Cora Therapeutics Announces $1M in Seed Funding
Cora Therapeutics, a Toronto-based life sciences start-up, is pleased to announce the company has raised […]
Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors
Aadi Bioscience, a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined […]
NeuroSense Therapeutics & Massachusetts General Hospital's NeuroEpigenetics Lab to Collaborate on Elucidating Neurotherapeutic Effects of PrimeC in ALS
NeuroSense Therapeutics, a company developing treatments for severe neurodegenerative diseases, today announced it has signed […]
Meliora Therapeutics Appoints Claudio Chuaqui as Head of Drug Discovery
Meliora Therapeutics, a biotech company pioneering a machine learning-driven approach to mechanism-driven oncology drug development, […]
Vertex and CRISPR Therapeutics Announce Licensing Agreement
Vertex Pharmaceuticals and CRISPR Therapeutics today announced that they have entered into a new non-exclusive […]
SolasCure Announces Final Closing of £10.9m Series B Fundraise to Advance Wound Care Innovation
SolasCure, a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which […]
GeminiBio Strengthens Board of Directors with Addition of Bryan Poltilove
Gemini BioProducts (GeminiBio), a portfolio company of BelHealth, a Florida-based healthcare private equity firm, and […]
Celyad Oncology Appoints Georges Rawadi as Its New CEO
Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]
Companion Spine Closes $60.1 Million Series A Funding Round
Companion Spine, the French-American specialist in interventional spine pain-management surgery, today announced the successful closing […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more